Back

Neutralizing Antibody Responses in COVID-19 Convalescent Sera

2020-07-11 infectious diseases Title + abstract only
View on medRxiv
Show abstract

Passive transfer of antibodies from COVID-19 convalescent patients is being used as an experimental treatment for eligible patients with SARS-CoV-2 infections. The United States Food and Drug Administrations (FDA) guidelines for convalescent plasma recommends target antibody titers of 160. We evaluated SARS-CoV-2 neutralizing antibodies in sera from recovered COVID-19 patients using plaque reduction neutralization tests (PRNT) at low (PRNT50) and high (PRNT90) stringency thresholds. We found tha...

Predicted journal destinations

1
The Journal of Infectious Diseases
137 training papers
#1 11.2%
2
Clinical Infectious Diseases
219 training papers
Top 2% 8.6%
3
Nature Communications
483 training papers
Top 14% 7.4%
4
PLOS ONE
1737 training papers
Top 75% 6.1%
5
Scientific Reports
701 training papers
Top 58% 4.8%
6
Viruses
79 training papers
Top 0.9% 3.7%
7
Journal of Medical Virology
95 training papers
Top 4% 2.7%
8
Open Forum Infectious Diseases
124 training papers
Top 5% 2.7%
9
Journal of Clinical Microbiology
77 training papers
Top 3% 1.8%
10
Cell Reports Medicine
49 training papers
Top 2% 1.8%
11
JCI Insight
63 training papers
Top 3% 1.8%
12
mBio
34 training papers
Top 0.3% 1.8%
13
Microbiology Spectrum
86 training papers
Top 3% 1.8%
14
Emerging Infectious Diseases
84 training papers
Top 6% 1.8%
15
Frontiers in Immunology
140 training papers
Top 6% 1.8%
16
mSphere
27 training papers
Top 0.2% 1.8%
17
PLOS Pathogens
35 training papers
Top 0.7% 1.5%
18
Journal of Clinical Investigation
50 training papers
Top 3% 1.5%
19
Science Translational Medicine
40 training papers
Top 2% 1.5%
20
International Journal of Infectious Diseases
115 training papers
Top 13% 1.5%
21
The Lancet Microbe
33 training papers
Top 0.5% 1.5%
22
Nature Medicine
88 training papers
Top 6% 1.5%
23
Cell
28 training papers
Top 1% 1.3%
24
Journal of Clinical Virology
54 training papers
Top 4% 1.3%
25
New England Journal of Medicine
49 training papers
Top 2% 1.3%
26
eBioMedicine
82 training papers
Top 6% 1.3%
27
Science
46 training papers
Top 4% 1.1%
28
Med
26 training papers
Top 0.5% 1.1%
29
The Lancet Infectious Diseases
57 training papers
Top 7% 0.9%
30
iScience
74 training papers
Top 11% 0.9%